Palantir stock is a "Strong Buy" given its growth and EPS outlook, despite a premium valuation. Here's what investors need to ...

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Is this Warren Buffett’s final trick? | Trustn ...

I was surprised to discover that only a very small number of companies have managed to retain their status as the “most ...

My friend Jaye and her husband raised their two children in a 560-square-foot apartment in New York City. Most of their domestic life unfolded in a sprawling living room framed by two minimalist ...

The price-to-book ratio, or P/B ratio, looks at a company from a different angle. It compares the stock’s market ...

Ahead of Apple’s 50th anniversary, RR Auction is auctioning a trove of historic artifacts, including the first check written ...

This increase propelled the shares to more than 32x forward earnings—a premium valuation that hinges on Apple’s success in ...

Apple stock underperformed against the S&P 500 and Nasdaq 100 in 2025, but CEO Tim Cook still took home an impressive ...

Apple (AAPL) executive pay dips in 2025 as shareholders weigh a “China entanglement audit” amid tariff risks—get key SEC ...

Alphabet Inc. has overtaken Apple Inc. to become the second-most valuable company by market capitalization, a reflection of ...

DENTSPLY SIRONA’s latest update trims its fair value estimate slightly from US$12.96 to US$12.83 per share, while also adjusting key model inputs like the discount rate and revenue growth assumptions.

Why Teva’s Price Target Just Got Nudged Higher Teva Pharmaceutical Industries just saw its fair value estimate move from ...